Jonathan Root - Feb 25, 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
Dale Holladay, Attorney in Fact for the Reporting Person
Stock symbol
EWTX
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 07:04 PM
Previous filing
Dec 15, 2021
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Other -3.47M -100% 0 Feb 25, 2022 Directly owned by USVP XI F1, F2
holding EWTX Common Stock 15.6K Feb 25, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro-rata, in-kind distribution by U.S. Venture Partners XI, L.P. without additional consideration to its partners.
F2 These securities are held of record by U.S. Venture Partners XI, L.P. (''USVP XI''). Presidio Management Group XI, L.L.C. ("PMG XI"), the general partner of USVP XI, has sole voting and dispositive power with respect to the shares held by USVP XI. The Reporting Person is a managing member of PMG XI with additional rights with respect to the issuer's securities, and may be deemed to have sole voting and dispositive power with respect to such shares. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.